WEST LAFAYETTE, Ind., Feb. 17, 2015 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for personalized therapy, today announced that the company's management team will present at the following upcoming healthcare conferences.
2015 RBC Capital Market's Healthcare Conference – Tuesday, Feb. 24, at 2:35 p.m. EST. The conference will be held at the New York Palace Hotel in New York City.
Cowen and Company 35th Annual Health Care Conference – Tuesday, Mar. 3, at 10:40 a.m. EST. The conference will be held at the Boston Marriott Copley Place.
Webcast information can be accessed under "Events & Presentations" in the Investors & News section of Endocyte's website at www.endocyte.com. All webcasts will be archived shortly after each live event and a replay will be available on the Company's website for 90 days following the conference.
Endocyte is a biopharmaceutical company and leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for personalized therapy in cancer and other serious diseases. Endocyte uses its proprietary technology to create novel SMDCs and companion imaging agents for personalized targeted therapies. The company's SMDCs actively target receptors that are expressed or over-expressed on diseased cells, relative to healthy cells. This targeted approach is designed to enable the treatment of patients with highly potent drugs into these cells. The companion imaging agents are designed to identify patients whose disease expresses the molecular target of the therapy and who therefore may be more likely to benefit from treatment. For more information, visit http://www.endocyte.com.
CONTACT: Stephanie Ascher, Stern Investor Relations, Inc., (212) 362-1200, email@example.com